Your browser doesn't support javascript.
loading
Health-related quality of life of patients with colorectal neoplasms in China: A multicenter cross-sectional survey.
Huang, Hui-Yao; Wang, Hong; Shi, Ju-Fang; Bai, Ya-Na; Wang, Le; Liu, Cheng-Cheng; Yan, Xin-Xin; Liu, Guo-Xiang; Liao, Xian-Zhen; Shi, Dian; Mao, A-Yan; Ren, Jian-Song; Sun, Xiao-Jie; Guan, Hai-Jing; Huang, Wei-Dong; Lei, Hai-Ke; Gong, Ji-Yong; Liu, Yun-Yong; Zhu, Lin; Song, Bing-Bing; Du, Lin-Bing; Guo, Lan-Wei; Liu, Yu-Qin; Ren, Ying; Lan, Li; Zhou, Jin-Yi; Qi, Xiao; Sun, Xiao-Hua; Lou, Pei-An; Wu, Shou-Ling; Tang, Yu; Li, Ni; Zhang, Kai; Li, Ning; Chen, Wan-Qing; Dai, Min; He, Jie.
Afiliação
  • Huang HY; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang H; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Shi JF; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Bai YN; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang L; Institute of Epidemiology and Health Statistics, Lanzhou University, Lanzhou, China.
  • Liu CC; Department of Cancer Prevention, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Cancer and Basic Medicine(ICBM), Chinese Academy of Sciences, Hangzhou, China.
  • Yan XX; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liu GX; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liao XZ; Department of Health Economics, School of Health Management, Harbin Medical University, Harbin, China.
  • Shi D; Hunan Office for Cancer Control and Research, Hunan Provincial Cancer Hospital, Changsha, China.
  • Mao AY; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Ren JS; Institute of Epidemiology and Health Statistics, Lanzhou University, Lanzhou, China.
  • Sun XJ; Public Health Information Research Office, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, China.
  • Guan HJ; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Huang WD; Center for Health Management and Policy, Key Lab of Health Economics and Policy, Shandong University, Jinan, China.
  • Lei HK; China Center for Health Economic Research, Peking University, Beijing, China.
  • Gong JY; Department of Health Economics, School of Health Management, Harbin Medical University, Harbin, China.
  • Liu YY; Chongqing Office for Cancer Control and Research, Chongqing Cancer Hospital, Chongqing, China.
  • Zhu L; Science and Education Department of Public Health Division, Shandong Tumor Hospital, Jinan, China.
  • Song BB; Liaoning Office for Cancer Control and Research, Liaoning Cancer Hospital and Institute, Shenyang, China.
  • Du LB; Teaching and Research Department, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.
  • Guo LW; Heilongjiang Office for Cancer Control and Research, Affiliated Cancer Hospital of Harbin Medical University, Harbin, China.
  • Liu YQ; Department of Cancer Prevention, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Cancer and Basic Medicine(ICBM), Chinese Academy of Sciences, Hangzhou, China.
  • Ren Y; Department of Institute of Tumor Research, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Lan L; Cancer Epidemiology Research Center, Gansu Provincial Cancer Hospital, Lanzhou, China.
  • Zhou JY; Urban Office of Cancer Early Detection and Treatment, Tieling Central Hospital, Tieling, China.
  • Qi X; Institute of Chronic disease prevention and control, Harbin Center for Disease Control and Prevention, Harbin, China.
  • Sun XH; Institute of Chronic Non-communicable Diseases Prevention and Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
  • Lou PA; Department of Occupational Medicine, Tangshan People's Hospital, Tangshan, China.
  • Wu SL; Ningbo Clinical Cancer Prevention Guidance Center, Ningbo No. 2 Hospital, Ningbo, China.
  • Tang Y; Department of Control and Prevention of Chronic Non-communicable Diseases, Xuzhou Center for Disease Control and Prevention, Xuzhou, China.
  • Li N; Health Department of Kailuan Group, Kailuan General Hospital, Tangshan, China.
  • Zhang K; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Li N; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Chen WQ; Department of Physical Examination on Cancer, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Dai M; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • He J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Gastroenterol Hepatol ; 36(5): 1197-1207, 2021 May.
Article em En | MEDLINE | ID: mdl-32875595
ABSTRACT
BACKGROUND AND

AIM:

This study aimed to clarify health-related quality of life (HRQoL) of patients with colorectal precancer and colorectal cancer (CRC) in China and to better understand related utility scores.

METHODS:

A hospital-based cross-sectional survey was conducted in precancer and CRC patients from 2012 to 2014, covering 12 provinces in China. HRQoL was assessed with EuroQol 5-Dimensions 3-Levels. Utility scores were derived using Chinese value set. A multivariate regression model was established to explore potential predictors of utility scores.

RESULTS:

A total of 376 precancer (mean age 58.7 years, 61.2% men) and 2470 CRC patients (mean age 58.6 years, 57.6% men) were included. In five dimensions, there was a certain percentage of problem reported among precancer (range 12.0% to 36.7%) and CRC (range 32.4% to 50.3%) patients, with pain/discomfort being the most serious dimension. Utility scores of precancer and CRC patients were 0.870 (95% confidence interval [CI], 0.855-0.886) and 0.751 (95% CI, 0.742-0.759), both of which were lower than those of general Chinese population (0.960 [95% CI, 0.960-0.960]). Utilities for patients at stage I to stage IV were 0.742 (95% CI, 0.715-0.769), 0.722 (95% CI, 0.705-0.740), 0.756 (95% CI, 0.741-0.772), and 0.745 (95% CI, 0.742-0.767), respectively. Multivariate analysis showed that therapeutic regimen, time point of the interview, education, occupation, annual household income, and geographic region were associated with utilities of CRC patients.

CONCLUSION:

Health-related quality of life of both precancer and CRC patients in China declined considerably. Utility scores differed by sociodemographic and clinical characteristics, and findings of these utilities may facilitate implementation of further cost-utility evaluations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Colorretais País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Colorretais País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China